Paola Porcari et al 2006 Phys. Med. Biol. 51 3141 doi:10.1088/0031-9155/51/12/010
Paola Porcari1,2,3, Silvia Capuani2,3, Renzo Campanella4, Angela La Bella5, Luisa Maria Migneco5 and Bruno Maraviglia1,3,6
Show affiliationsReaction yield optimization for the synthesis and the complexation of a boron neutron capture therapy agent 19F-labelled, 10B-enriched p-boronophenylalanine-fructose (19F-BPA-fr) complex was obtained. 1H, 19F, 13C and 10B magnetic resonance spectroscopy (MRS) of the 19F-BPA-fr complex in aqueous and rat blood solution phantoms and its spatial distribution mapping using 19F magnetic resonance imaging (MRI) results are reported. 7 T and 9.4 T magnetic fields were used to perform MRI and MRS respectively. Our in vitro results suggest that in vivo studies on 19F-BPA through 19F NMR will be feasible.
87.53.Bn Dosimetry/exposure assessment
Issue 12 (21 June 2006)
Received 13 March 2006
Published 6 June 2006
Paola Porcari et al 2006 Phys. Med. Biol. 51 3141
César Esteban et al. 2009 ApJ 700 654
T P Flanagan 1957 J. Sci. Instrum. 34 450
S K Bhattacharya and S -I Chu 1985 J. Phys. B: At. Mol. Phys. 18 L275
Edson D Leonel and P V E McClintock 2006 J. Phys. A: Math. Gen. 39 11399
Pei-Qing Jin et al 2006 J. Phys. A: Math. Gen. 39 7115
O E Barndorff-Nielsen and R D Gill 2000 J. Phys. A: Math. Gen. 33 4481
V. M. Kaspi et al. 2001 ApJ 560 371
E A Schiff 2004 J. Phys.: Condens. Matter 16 S5265
Jacqueline Kessler-Silacci et al. 2006 ApJ 639 275